Ameriprise’s Heron Therapeutics HRTX Stock Holding History

Ameriprise’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-277,538	Closed	-$286K	–	3929
2023 Q3	$286K	Sell	277,538 -9,633	-3%	-$9.92K	﹤0.01%	3598
2023 Q2	$333K	Sell	287,171 -65,603	-19%	-$76.1K	﹤0.01%	3578
2023 Q1	$533K	Buy	352,774 +100,133	+40%	+$151K	﹤0.01%	3409
2022 Q4	$631K	Buy	252,641 +3,435	+1%	+$8.58K	﹤0.01%	3316
2022 Q3	$1.05M	Sell	249,206 -9,029	-3%	-$38.1K	﹤0.01%	3089
2022 Q2	$720K	Buy	258,235 +36,677	+17%	+$102K	﹤0.01%	3250
2022 Q1	$1.27M	Buy	221,558 +25,665	+13%	+$147K	﹤0.01%	3107
2021 Q4	$1.79M	Buy	195,893 +28,314	+17%	+$258K	﹤0.01%	2989
2021 Q3	$1.79M	Buy	167,579 +41,146	+33%	+$440K	﹤0.01%	2907
2021 Q2	$1.96M	Buy	126,433 +42,411	+50%	+$658K	﹤0.01%	2938
2021 Q1	$1.36M	Sell	84,022 -16,915	-17%	-$274K	﹤0.01%	3006
2020 Q4	$2.14M	Sell	100,937 -4,914	-5%	-$104K	﹤0.01%	2765
2020 Q3	$1.57M	Sell	105,851 -30,977	-23%	-$459K	﹤0.01%	2781
2020 Q2	$2.01M	Sell	136,828 -43,635	-24%	-$641K	﹤0.01%	2604
2020 Q1	$2.12M	Buy	180,463 +59,304	+49%	+$696K	﹤0.01%	2443
2019 Q4	$2.85M	Buy	121,159 +26,471	+28%	+$622K	﹤0.01%	2554
2019 Q3	$1.75M	Buy	94,688 +5,925	+7%	+$110K	﹤0.01%	2761
2019 Q2	$1.65M	Sell	88,763 -10,443	-11%	-$194K	﹤0.01%	2851
2019 Q1	$2.42M	Sell	99,206 -72,037	-42%	-$1.76M	﹤0.01%	2647
2018 Q4	$4.44M	Buy	171,243 +89,951	+111%	+$2.33M	﹤0.01%	2196
2018 Q3	$2.57M	Buy	81,292 +13,889	+21%	+$440K	﹤0.01%	2713
2018 Q2	$2.62M	Buy	67,403 +16,337	+32%	+$635K	﹤0.01%	2609
2018 Q1	$1.41M	Buy	+51,066	New	+$1.41M	﹤0.01%	2822
2015 Q3	–	Sell	-114,472	Closed	-$3.57M	–	3855
2015 Q2	$3.57M	Buy	114,472 +37,870	+49%	+$1.18M	﹤0.01%	2361
2015 Q1	$1.12M	Buy	+76,602	New	+$1.12M	﹤0.01%	2888